hasINN

P23160
predicate

Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.

All labels observed (1)

Label Occurrences
hasINN canonical 30

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasINN
Generated description
Indicates that a pharmaceutical product or substance is associated with a specific International Nonproprietary Name (INN) assigned by the World Health Organization.

Sample triples (30)

Subject Object
Leqembi lecanemab
linked to: Leqembi
Imbruvica ibrutinib
Avastin bevacizumab
linked to: Avastin
Rituxan rituximab
linked to: Rituxan
Donepezil donepezil
linked to: Donepezil
Alimta pemetrexed
linked to: Alimta
Emgality galcanezumab
linked to: Emgality
Ruxience rituximab
linked to: Rituxan
Keytruda pembrolizumab NERFINISHED
maftivimab maftivimab NERFINISHED
Inmazeb atoltivimab
Inmazeb maftivimab NERFINISHED
Inmazeb odesivimab NERFINISHED
Ibrance palbociclib NERFINISHED
Imfinzi durvalumab NERFINISHED
fingolimod fingolimod NERFINISHED
larotrectinib larotrectinib NERFINISHED
selpercatinib selpercatinib
inotersen inotersen
Humira adalimumab
Hemlibra emicizumab
Vabysmo faricimab NERFINISHED
rosuvastatin rosuvastatin
sulfasalazine sulfasalazine
Andexxa andexanet alfa NERFINISHED
Ondexxya andexanet alfa NERFINISHED
isatuximab isatuximab
Zabdeno Ad26.ZEBOV
acalabrutinib acalabrutinib NERFINISHED
neratinib neratinib NERFINISHED